- Report
- March 2024
- 143 Pages
Global
From €3873EUR$3,899USD£3,221GBP
- Report
- August 2024
- 135 Pages
Global
From €3873EUR$3,899USD£3,221GBP
- Report
- August 2024
- 145 Pages
Global
From €3873EUR$3,899USD£3,221GBP
- Report
- July 2024
- 138 Pages
Global
From €3873EUR$3,899USD£3,221GBP
- Report
- April 2024
- 137 Pages
Global
From €3873EUR$3,899USD£3,221GBP
- Report
- April 2024
- 137 Pages
Global
From €3873EUR$3,899USD£3,221GBP
- Report
- December 2023
- 140 Pages
Global
From €4421EUR$4,450USD£3,676GBP
- Report
- July 2024
- 109 Pages
Global
From €4719EUR$4,750USD£3,924GBP
- Report
- February 2024
- 130 Pages
Global
From €4719EUR$4,750USD£3,924GBP
- Drug Pipelines
- July 2024
- 150 Pages
Global
From €2608EUR$2,625USD£2,168GBP
€3725EUR$3,750USD£3,098GBP
- Report
- July 2024
- 100 Pages
Global
From €2608EUR$2,625USD£2,168GBP
€3725EUR$3,750USD£3,098GBP
- Report
- July 2024
- 100 Pages
Global
From €2608EUR$2,625USD£2,168GBP
€3725EUR$3,750USD£3,098GBP
- Report
- July 2024
- 150 Pages
Global
From €2608EUR$2,625USD£2,168GBP
€3725EUR$3,750USD£3,098GBP
- Report
- July 2024
- 100 Pages
Global
From €2608EUR$2,625USD£2,168GBP
€3725EUR$3,750USD£3,098GBP
- Report
- July 2024
- 100 Pages
Global
From €2608EUR$2,625USD£2,168GBP
€3725EUR$3,750USD£3,098GBP
- Report
- July 2024
- 100 Pages
Global
From €2608EUR$2,625USD£2,168GBP
€3725EUR$3,750USD£3,098GBP
- Report
- July 2024
- 100 Pages
Global
From €2608EUR$2,625USD£2,168GBP
€3725EUR$3,750USD£3,098GBP
- Report
- April 2024
- 182 Pages
Global
From €4471EUR$4,500USD£3,717GBP
- Report
- February 2024
- 185 Pages
Global
From €4471EUR$4,500USD£3,717GBP
- Report
- August 2024
- 169 Pages
Global
From €2484EUR$2,500USD£2,065GBP
The Inhalers and Nebulisers market is a segment of the medical device industry that focuses on the development and production of devices used to deliver medication to the lungs. Inhalers and nebulisers are used to treat a variety of respiratory conditions, including asthma, COPD, and cystic fibrosis. Inhalers are handheld devices that deliver medication directly to the lungs in the form of a mist or aerosol. Nebulisers are larger devices that use a compressor to convert liquid medication into a mist that can be inhaled.
Inhalers and nebulisers are used by millions of people around the world, and the market is expected to grow in the coming years. Companies in the market include GlaxoSmithKline, Boehringer Ingelheim, AstraZeneca, Novartis, and Teva Pharmaceuticals. These companies are involved in the development and production of inhalers and nebulisers, as well as the research and development of new treatments for respiratory conditions. Show Less Read more